Bionexus Gene Lab Adopts Ethereum in Groundbreaking Treasury Move
Bionexus Gene Lab Corp (BGLC) has made history as the first Nasdaq-listed company to adopt an Ethereum-focused treasury strategy.
On March 6, the company announced that its board approved the move to prioritize Ethereum (ETH) as a strategic treasury asset, citing Ethereum’s liquidity, utility, and institutional credibility. CEO Sam Tan highlighted the role of Wyoming’s blockchain-friendly laws in supporting this decision. BGLC aims to integrate Ethereum and blockchain technology into its operations, with a focus on financial applications and treasury management.
The company also plans to leverage Ethereum’s potential to enhance financial resilience and attract innovative investors.
Clever Robot News Desk 8th March 2025
